584 related articles for article (PubMed ID: 32828637)
1. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway.
Shayota BJ; Donti TR; Xiao J; Gijavanekar C; Kennedy AD; Hubert L; Rodan L; Vanderpluym C; Nowak C; Bjornsson HT; Ganetzky R; Berry GT; Pappan KL; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2020; 131(1-2):147-154. PubMed ID: 32828637
[TBL] [Abstract][Full Text] [Related]
2. Transaldolase deficiency in a two-year-old boy with cirrhosis.
Wamelink MM; Struys EA; Salomons GS; Fowler D; Jakobs C; Clayton PT
Mol Genet Metab; 2008 Jun; 94(2):255-8. PubMed ID: 18331807
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characteristics of two transaldolase-deficient patients.
Tylki-Szymanska A; Wamelink MM; Stradomska TJ; Salomons GS; Taybert J; Dąbrowska-Leonik N; Rurarz M
Eur J Pediatr; 2014 Dec; 173(12):1679-82. PubMed ID: 24497183
[TBL] [Abstract][Full Text] [Related]
4. Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway.
Verhoeven NM; Huck JH; Roos B; Struys EA; Salomons GS; Douwes AC; van der Knaap MS; Jakobs C
Am J Hum Genet; 2001 May; 68(5):1086-92. PubMed ID: 11283793
[TBL] [Abstract][Full Text] [Related]
5. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.
Coene KLM; Kluijtmans LAJ; van der Heeft E; Engelke UFH; de Boer S; Hoegen B; Kwast HJT; van de Vorst M; Huigen MCDG; Keularts IMLW; Schreuder MF; van Karnebeek CDM; Wortmann SB; de Vries MC; Janssen MCH; Gilissen C; Engel J; Wevers RA
J Inherit Metab Dis; 2018 May; 41(3):337-353. PubMed ID: 29453510
[TBL] [Abstract][Full Text] [Related]
6. [Transaldolase deficiency - clinical outcome, pathogenesis, diagnostic process].
Lipiński P; Stradomska T; Tylki-Szymańska A
Dev Period Med; 2018; 22(2):187-196. PubMed ID: 30056406
[TBL] [Abstract][Full Text] [Related]
7. Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: Update of 34 patients.
Williams M; Valayannopoulos V; Altassan R; Chung WK; Heijboer AC; Keng WT; Lapatto R; McClean P; Mulder MF; Tylki-Szymańska A; Walenkamp ME; Alfadhel M; Alakeel H; Salomons GS; Eyaid W; Wamelink MMC
J Inherit Metab Dis; 2019 Jan; 42(1):147-158. PubMed ID: 30740741
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify Inborn Errors of Metabolism.
Liu N; Xiao J; Gijavanekar C; Pappan KL; Glinton KE; Shayota BJ; Kennedy AD; Sun Q; Sutton VR; Elsea SH
JAMA Netw Open; 2021 Jul; 4(7):e2114155. PubMed ID: 34251446
[TBL] [Abstract][Full Text] [Related]
9. Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders.
Burrage LC; Thistlethwaite L; Stroup BM; Sun Q; Miller MJ; Nagamani SCS; Craigen W; Scaglia F; Sutton VR; Graham B; Kennedy AD; ; Milosavljevic A; Lee BH; Elsea SH
Genet Med; 2019 Sep; 21(9):1977-1986. PubMed ID: 30670878
[TBL] [Abstract][Full Text] [Related]
10. Detection of transaldolase deficiency by quantification of novel seven-carbon chain carbohydrate biomarkers in urine.
Wamelink MM; Smith DE; Jansen EE; Verhoeven NM; Struys EA; Jakobs C
J Inherit Metab Dis; 2007 Oct; 30(5):735-42. PubMed ID: 17603756
[TBL] [Abstract][Full Text] [Related]
11. Hypergonadotrophic hypogonadism in a patient with transaldolase deficiency: novel mutation in the pentose phosphate pathway.
Lafcı NG; Colak FK; Sahin G; Sakar M; Çetinkaya S; Savas-Erdeve S
Hormones (Athens); 2021 Sep; 20(3):581-585. PubMed ID: 33159679
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial involvement and erythronic acid as a novel biomarker in transaldolase deficiency.
Engelke UF; Zijlstra FS; Mochel F; Valayannopoulos V; Rabier D; Kluijtmans LA; Perl A; Verhoeven-Duif NM; de Lonlay P; Wamelink MM; Jakobs C; Morava E; Wevers RA
Biochim Biophys Acta; 2010 Nov; 1802(11):1028-35. PubMed ID: 20600873
[TBL] [Abstract][Full Text] [Related]
13. Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype.
Eyaid W; Al Harbi T; Anazi S; Wamelink MM; Jakobs C; Al Salammah M; Al Balwi M; Alfadhel M; Alkuraya FS
J Inherit Metab Dis; 2013 Nov; 36(6):997-1004. PubMed ID: 23315216
[TBL] [Abstract][Full Text] [Related]
14. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review.
Wamelink MM; Struys EA; Jakobs C
J Inherit Metab Dis; 2008 Dec; 31(6):703-17. PubMed ID: 18987987
[TBL] [Abstract][Full Text] [Related]
15. Nephrological abnormalities in patients with transaldolase deficiency.
Loeffen YG; Biebuyck N; Wamelink MM; Jakobs C; Mulder MF; Tylki-Szymańska A; Fung CW; Valayannopoulos V; Bökenkamp A
Nephrol Dial Transplant; 2012 Aug; 27(8):3224-7. PubMed ID: 22510381
[TBL] [Abstract][Full Text] [Related]
16. Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency.
Huck JH; Struys EA; Verhoeven NM; Jakobs C; van der Knaap MS
Clin Chem; 2003 Aug; 49(8):1375-80. PubMed ID: 12881455
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of the complex metabolic profile of cerebrospinal fluid using an untargeted biochemical profiling assay.
Kennedy AD; Pappan KL; Donti TR; Evans AM; Wulff JE; Miller LAD; Reid Sutton V; Sun Q; Miller MJ; Elsea SH
Mol Genet Metab; 2017 Jun; 121(2):83-90. PubMed ID: 28412083
[TBL] [Abstract][Full Text] [Related]
18. Metabolic pathway engineering based on metabolomics confers acetic and formic acid tolerance to a recombinant xylose-fermenting strain of Saccharomyces cerevisiae.
Hasunuma T; Sanda T; Yamada R; Yoshimura K; Ishii J; Kondo A
Microb Cell Fact; 2011 Jan; 10(1):2. PubMed ID: 21219616
[TBL] [Abstract][Full Text] [Related]
19. Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure.
Balasubramaniam S; Wamelink MM; Ngu LH; Talib A; Salomons GS; Jakobs C; Keng WT
J Pediatr Gastroenterol Nutr; 2011 Jan; 52(1):113-6. PubMed ID: 21119539
[No Abstract] [Full Text] [Related]
20. An evaluation of untargeted metabolomics methods to characterize inborn errors of metabolism.
Wurth R; Turgeon C; Stander Z; Oglesbee D
Mol Genet Metab; 2024 Jan; 141(1):108115. PubMed ID: 38181458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]